L87.8 Other transepidermal elimination disorders

Name of the Condition

• Other transepidermal elimination disorders

Summary

Other transepidermal elimination disorders are a heterogeneous group of rare skin conditions characterized by abnormal elimination of substances through the epidermis, resulting in distinctive skin lesions. These disorders involve the extrusion of material such as keratin, collagen, or other substances through the skin surface, often leading to papules, nodules, or plaques. The underlying mechanisms typically relate to impaired skin barrier function or abnormal tissue processing, and they are considered part of the broader category of transepidermal elimination disorders.

Causes

The exact causes of other transepidermal elimination disorders are not fully understood but are thought to involve dysregulation of skin cell turnover or extracellular matrix components. Some cases may be associated with genetic factors, autoimmune processes, or underlying systemic conditions that affect skin integrity. The elimination of substances through the epidermis is believed to be a reactive process to abnormal material accumulation in the skin.

Risk Factors

• Genetic predisposition: Some forms may have familial patterns.
• Underlying systemic diseases: Conditions affecting skin or connective tissue may increase risk.
• Age: Certain subtypes may be more common in specific age groups.
• Skin trauma or irritation: May trigger or exacerbate lesions in susceptible individuals.

Symptoms

• Persistent papules, nodules, or plaques, often with a central plug or extruded material.
• Lesions may be pruritic, tender, or asymptomatic.
• Distribution varies by subtype but commonly affects areas of friction or pressure (e.g., extremities, trunk).
• Lesions may evolve over time, with extrusion of keratin, collagen, or other dermal components.

Diagnosis

Diagnosis is based on clinical presentation, including the characteristic appearance and distribution of lesions, and may be supported by histopathological examination. Biopsy typically shows transepidermal elimination of material, such as collagen or keratin, with associated epidermal changes. Clinical correlation is essential to distinguish these disorders from other dermatologic conditions, and additional testing (e.g., genetic or systemic workup) may be considered if underlying causes are suspected.

Treatment Options

Treatment is often symptomatic and tailored to the individual. Topical therapies (e.g., keratolytics, corticosteroids) may help reduce lesion size or pruritus. Systemic agents (e.g., retinoids, immunosuppressants) may be used in refractory cases. Management of underlying conditions (e.g., diabetes, autoimmune disorders) is important when applicable. Lesions may resolve spontaneously or persist, requiring ongoing monitoring and adjustment of therapy.

Prognosis and Follow-Up

Prognosis varies by subtype and individual factors. Some lesions may resolve with treatment or spontaneously, while others may persist or recur. Regular follow-up is recommended to monitor for changes in lesion activity, potential complications, or response to therapy. Long-term management may be necessary for chronic or recurrent cases.

Complications

• Secondary infection: Open lesions may increase risk of bacterial or fungal infection.
• Scarring or hyperpigmentation: Persistent or treated lesions may leave residual changes.
• Discomfort or pruritus: May affect quality of life, particularly with extensive involvement.
• Psychological impact: Visible lesions may cause distress or social stigma.

Lifestyle & Prevention

• Avoid skin trauma or irritation: Protect affected areas from friction or injury.
• Gentle skin care: Use mild cleansers and moisturizers to maintain skin barrier function.
• Sun protection: Minimize UV exposure to reduce skin damage.
• Manage underlying conditions: Address systemic factors (e.g., diabetes, autoimmune disease) that may contribute to skin changes.

When to Seek Professional Help

Seek medical evaluation if lesions are painful, rapidly changing, or associated with signs of infection (e.g., redness, drainage). Prompt care is recommended for new or worsening symptoms, especially if they impact daily activities or quality of life. Dermatologic consultation is advised for persistent or atypical lesions to confirm diagnosis and guide management.

Tips for Medical Coders

When coding for other transepidermal elimination disorders (ICD-10-CM code L87.8), ensure documentation supports the diagnosis, including clinical description of lesions, distribution, and any associated findings. Verify that the condition is not better classified under a more specific transepidermal elimination disorder code. Document any underlying causes or contributing factors (e.g., systemic diseases) to support medical necessity and coding accuracy.